DarioHealth Corp. DRIO
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- -73.64%
- 1 year
- -78.17%
- Market cap
- 29.40M
- Revenue (ttm)
- 23.05M
- Profit margin
- -205.62%
- EPS (ttm)
- -2.28
- Shares out
- 34.10M
- Forward P/E
- -0.87
- YTD return
- -73.64%
- 1-year return
- -78.17%
- Volume
- 71.59K
- Avg volume
- 38.22K
- Open
- 2.97
- Previous close
- 3.03
- Day's range
- 2.88 – 3.09
- 52-week range
- 2.88 – 14.77
- Price target
- 3.50 (+16.7%)
1D -0.03 (-0.99%)
Key statistics
- Enterprise value
- 42.22M
- PEG ratio
- 0.00
- Price / sales
- 1.03
- Price / book
- 0.37
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 111.00%
- Free cash flow
- -26.87M
- Total cash
- 15.55M
- Total debt
- 30.49M
- Return on equity
- -74.91%
- Short % of float
- 6.22%
- 50-day average
- 0.85246
- 200-day average
- 1.14
Analyst view
- Target (low)
- 2.00
- Target (mean)
- 3.50
- Target (high)
- 5.00
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.16.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.18 | -0.13 | +0.05 | +27.78% |
| Aug 8, 2024 | Jun 1, 2024 | -0.29 | 0.06 | +0.35 | +120.69% |
| May 15, 2024 | Mar 1, 2024 | -0.59 | -0.20 | +0.39 | +66.10% |
| Mar 28, 2024 | Dec 1, 2023 | -0.54 | -0.41 | +0.13 | +24.07% |
| Nov 2, 2023 | Sep 1, 2023 | -0.50 | -0.49 | +0.01 | +2.00% |
| Aug 10, 2023 | Jun 1, 2023 | -0.52 | -0.58 | -0.06 | -11.54% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 1, 2024 | Stifel | main | Buy | Buy |
| Aug 11, 2023 | Alliance Global Partners | main | Buy | Buy |
| Jul 25, 2023 | Stifel | main | Buy | Buy |
| May 12, 2023 | Craig-Hallum | main | Buy | Buy |
| Nov 16, 2022 | Alliance Global Partners | main | — | Buy |
| Aug 18, 2022 | Aegis Capital | main | — | Buy |
About DarioHealth Corp.
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- dariohealth.com
News
DarioHealth to Report Third Quarter 2026 Results on Thursday, November 12, 2026 
This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday 
BTIG Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $6 
DarioHealth Expands Contract With Dario To Add Dario Women, Recently Launched Women's Health Solution Supporting Women Navigating Perimenopause And Menopause Symptoms 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
12 Health Care Stocks Moving In Tuesday's Intraday Session
Your note
Sign in to keep a note on DRIO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEN-DAVID ZVI | Chief Financial Officer | Stock Award(Grant) | Mar 5, 2024 | 747,821 |
| KAPLAN JON H | Director | Stock Award(Grant) | Mar 5, 2024 | 70,000 |
| KARAH HILA | Director | Stock Award(Grant) | Mar 5, 2024 | 219,290 |
| MATHEIS DENNIS | Director | Stock Award(Grant) | Mar 5, 2024 | 152,620 |
| MCGRATH DENNIS M | Director | Stock Award(Grant) | Mar 5, 2024 | 154,744 |
| NELSON STEVEN CHARLES | Officer | Purchase | Sep 10, 2024 | 50,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 7.34% | 2,503,312 | 1.75M | Sep 29, 2024 |
| Appian Way Asset Management LP | 4.14% | 1,410,870 | 984.08K | Sep 29, 2024 |
| Phoenix Holdings Ltd. | 3.30% | 1,126,736 | 785.90K | Sep 29, 2024 |
| Y.D. More Investments Ltd | 2.21% | 753,782 | 525.76K | Sep 29, 2024 |
| Clal Insurance Enterprises Holdings Ltd | 1.50% | 512,175 | 357.24K | Sep 29, 2024 |
| Vanguard Group Inc | 1.07% | 363,675 | 253.66K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.04% | 355,607 | 248.03K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.44% | 151,434 | 105.63K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.19% | 63,346 | 44.18K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.18% | 59,854 | 41.75K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 36,053 | 25.15K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 11,331 | 7.90K | Oct 30, 2024 |